Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

Published: March 2013
No. of Pages: 148
   

Proteins exhibit high specificity and less immunogenicity and are widely used as therapeutic agents in the treatment of various disorders and diseases. There are more than 200 protein-based products currently being marketed; 90% of them are used as therapeutics. In order to improve their clinical potential, second generation recombinants are being developed, each exhibiting improved efficiency and potency depending on their applications.

The global protein engineering technologies market (2012-2017) report analyses the market by technology, products, applications, and geography. It also includes recent technology trends, patents, and funding analysis. In addition, it also covers factors driving and restraining the growth of the market and market scenario in the U.S., Europe, Asia, and Rest of the World (RoW).

The protein engineering market is driven by the need for drugs with improved efficiency and specificity, technological capabilities, rise of antibody based drugs, and steady growth in the therapeutic market. With growing incidences of cancer, autoimmune disorders, and infectious disease, spurt of new opportunities for growth of the market is expected by the end of this decade. However, development costs, stringent regulatory issues, and risk of failure of the drug in the testing phase restraints the growth of the market. Further, the availability of generics and patent infringements is posing a threat to the market.

The global protein engineering market is expected to grow at a CAGR of 10.9%; this growth is majorly fuelled by monoclonal antibodies, which is the fastest growing segment in therapeutics. The use of monoclonal antibodies in therapeutics such as oncology, auto immune and inflammatory diseases are expected to increase during the forecast period. Chinas growing interest in research of monoclonal antibodies is expected to increase market share further. The market is likely to face competition from the entry of generics; however, with many therapeutic proteins in the pipeline, the market is expected to grow exponentially. Insulin analogs, which are more efficient than the recombinant insulin, are also a contributing factor for growth of the market. Diagnostics is another segment in focus; monoclonal antibodies are being used extensively in diagnostics and in assays for research.

The report also profiles leading participants of the industry with their recent developments and other strategic industry activities. These include Genentech (U.S.), Amgen (U.S.), Roche (Switzerland), Eli Lilly (U.S.), Novartis (Switzerland), GlaxoSmithKline (U.K.), Bristol-Myers Squibb (U.S.), Johnson & Johnson (U.S.), Merck (U.S.), Pfizer (U.S.), Sanofi (France), Affymax (U.S.), Biogen Idec, (U.S.), Medimmune (U.S.) Affimed (Germany), and Obodies (New Zealand).

Scope of the Report

This technical report categorizes the market for protein engineering by geography, applications, products, and technology, forecasting the market revenue by analyzing current and future trends in therapeutics and diagnostics.These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Global Protein engineering, by Technology

  • Sequence modification
  • Glycosylation
  • Pegylation
  • Display technologies
  • Humanization technology
  • Hybrid technology
  • Transgenic mice

Global Protein engineering, by Product

  • mAb
  • Insulin
  • Others
  • EPO
  • Diagnostics
  • Research

Geographic Analysis

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • France
  • Germany
  • Italy
  • Asia
  • Indonesia
  • India
  • China
  • South Korea
  • Rest of the World (RoW)
  • Japan
  • Australia

Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017

Table Of Content

1 Introduction(Slide No. 18 - 23)
1.1 Key Take- Aways
1.2 Assumptions
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Primary And Secondary Sources

2 Executive Summary (Slide No. 24 - 27)

3 Protein Engineering Technologies – Landscape Analysis (Slide No. 28 - 45)
3.1 Technology - Introduction
3.2 Technology – Evolution
3.3 Market Segmentation
3.4 Protein And Antibody Engineering Technologies – Overview
3.4.1 Sequence Modification
3.4.2 Glycosylation
3.4.3 Pegylation
3.4.4 Display Technologies
3.4.5 Humanization Technology
3.4.6 Hybrid Technology
3.4.7 Production Systems
3.4.8 Mapping Of Protein Production Systems
3.4.9 Emerging Production Systems
3.5 Protein Engineering – Technology Value Chain Analysis

4 Applications (Slide No. 46 - 54)
4.1 Therapeutic Development – Overview
4.1.1 Insulin Analogs
4.1.2 Monoclonal Antibodies
4.1.3 Therapeutic Development - Erythropoietin & Others
4.2 Diagnostics
4.3 Research – Meganuclease Engineering / ZFP & TALENS Engineering

5 Market Landscape Analysis(Slide No. 55 - 92)
5.1 Global Protein Engineering Market Forecast
5.1.1 Introduction
5.1.2 Global Protein Engineering Market Forecast, By Geography
5.1.3 Global Protein Engineering Market Forecast, By Product
5.1.4 Global Protein Engineering Market Forecast, By Application
5.1.5 Global Protein Engineering Market Forecast, By Technology
5.2 Market Dynamics - Overview
5.2.1 Drivers – Description
5.2.2 Drivers’ Impact – Timeline
5.2.3 Restraints – Description
5.2.4 Restraints Impact – Timeline
5.2.5 Opportunities – Description
5.2.6 Threats – Description
5.2.7 Pestle Analysis
5.3 Market Segmentation, By Product
5.3.1 Insulin Analogs
5.3.1.1 Insulin Analog Market
5.3.1.2 Insulin Analog Market, By Geography
5.3.1.3 Market Share Analysis
5.3.2 Modified EPO
5.3.2.1 Modified EPO Market
5.3.2.2 Modified EPO Market, By Geography
5.3.3 Monoclonal Antibodies (MAB)
5.3.3.1 Monoclonal Antibodies Market
5.3.3.2 Monoclonal Antibodies Market, By Geography
5.3.3.3 Monoclonal Antibodies Market, By Application
5.3.3.4 Major Products In The Market
5.4 Other Proteins
5.4.1 Other Proteins Market
5.4.2 Other Proteins Market, By Geography
5.4.3 Diagnostic Proteins, By Geography

6 Geographic Analysis (Slide No. 93 - 100)
6.1 North America
6.2 Europe
6.3 Asia
6.4 Row

7 Technology And Product Portfolio (Slide No. 101 - 105)
7.1 Proprietary Technology Platforms
7.2 Product Pipeline Analysis Of Key Players

8 Competitive Landscape (Slide No. 106 - 111)
8.1 Introduction
8.2 Porter’s Five Force Analysis
8.3 Mergers & Acquisitions, 2009 – 2012
8.4 Partnerships & Collaborations, 2012 - 2013
8.5 New Product Launch, 2010 – 2012

9 Analyst Insights And Recommendation (Slide No. 112 - 114)
9.1 Strategic Recommendations

10 Company Profiles (Slide No. 115 - 146)
10.1 Genentech, Inc.
10.2 Amgen, Inc.
10.3 Biogen Idec, Inc.
10.4 Novartis Ag
10.5 Glaxo Smithkline Plc
10.6 Eli Lilly & Co
10.7 Bristol Myers Squibb Co.
10.8 Johnson & Johnson
10.9 Merck & Co., Inc.
10.10 Sanofi
10.11 Pfizer, Inc.
10.12 Regeneron Pharmaceuticals, Inc.
10.13 Eleven Biotherapeutics (U.S.)
10.14 Toolgen, Inc. (Korea)
10.15 Dna2.0, Inc. (U.S.)
10.16 Avidbiotics Corp. (U.S.)
10.17 Sigma-Aldrich Corp. (U.S.)
10.18 Xencor Inc.
10.19 Morphosys

List Of Tables (11 Tables)

Table - 1Global Protein Engineering Market Revenue, 2012 – 2017 ($Billion)
Table - 2Global Protein Engineering Market, By Geography, 2012 – 2017 ($Billion)
Table - 3Global Protein Engineering Market, By Product, 2012 – 2017 ($Billion)
Table - 4Global Protein Engineering Market, By Application, 2012 – 2017 ($Billion)
Table - 5Global Protein Engineering Market, By Technology, 2012 – 2017 ($Billion)
Table - 6Insulin Analogs Market, By Geography, 2012 – 2017 ($Billion)
Table - 7Modified Epo Market, By Geography, 2012 – 2017 ($Billion)
Table - 8MAB Market, By Geography, 2012 – 2017 ($Billion)
Table - 9MAB Market, By Application, 2012 – 2017 ($Billion)
Table - 10 Other Proteins Market, By Geography, 2012 – 2017 ($Billion)
Table - 11 Diagnostic Proteins Market, By Geography, 2012 – 2017 ($Billion)

List Of Figure (44 Figures)

Fig - 1 Global Protein Engineering Market, 2012 – 2017 ($Billion)
Fig - 2 Global Protein Engineering Market, 2012 – 2017 ($Billion)
Fig - 3 Global Protein Engineering Market, By Geography, 2012 (%)
Fig - 4 Growth Rate, By Geography, 2012 – 2017
Fig - 5 Global Protein Engineering Market By Geography, 2012 – 2017 ($Billion)
Fig - 6 Global Protein Engineering Market, By Product, 2012 (%)
Fig - 7 Growth Rate, By Product, 2012 – 2017
Fig - 8 Global Protein Engineering Market, By Product, 2012 – 2017 ($Billion)
Fig - 9 Global Protein Engineering Market, By Application, 2012 (%)
Fig - 10 Growth Rate, By Application, 2012 – 2017
Fig - 11 Global Protein Engineering Market, By Application, 2012 - 2017 ($Billion)
Fig - 12 Global Protein Engineering Market, By Technology, 2012 (%)
Fig - 13 Growth Rate, By Technology, 2012 – 2017
Fig - 14 Global Protein Engineering Market, By Technology, 2012 – 2017 ($Billion)
Fig - 15 Market Share Analysis
Fig - 16 Insulin Analogs Market, By Geography, 2012
Fig - 17 Insulin Analogs Market, By Geography, 2012 – 2017 ($Billion)
Fig - 18 Market Share Analysis, Key Players, 2012
Fig - 19 Market Share Analysis Of Epo, By Product, 2012
Fig - 20 Modified EPO Market, By Geography, 2012
Fig - 21 Modified EPO Market, By Geography, 2012 – 2017 ($Billion)
Fig - 22 Market Share Analysis Of Engineered Therapeutic Proteins, By Product, 2012
Fig - 23 MAB Market, By Geography, 2012
Fig - 24 MAB Market, By Geography, 2012 – 2017 ($Billion)
Fig - 25 MAB Market,By Application, 2012
Fig - 26 MAB Market, By Application, 2012 – 2017 ($Billion)
Fig - 27 Market Share Analysis Of Other Proteins, 2012
Fig - 28 Other Proteins Market, By Geography, 2012
Fig - 29 Other Proteins Market, By Geography, 2012 – 2017 ($Billion)
Fig - 30 Diagnostic Proteins Market, By Geography, 2012
Fig - 31 Diagnostic Proteins Market, By Geography, 2012 – 2017 ($Billion)
Fig - 32 Product Pipeline Of Key Players
Fig - 33 Growth Strategies
Fig - 34 Amgen, Inc., Total Revenue
Fig - 35 Biogen Idec, Inc., Total Revenue
Fig - 36 Novartis Ag, Total Revenue
Fig - 37 Glaxo Smithkline Plc, Total Revenue
Fig - 38 Eli Lilly & Co., Total Revenue
Fig - 39 Bristol Myers Squibb Co., Total Revenue
Fig - 40 Johnson & Johnson , Total Revenue
Fig - 41 Merck & Co., Inc., Total Revenue
Fig - 42 Sanofi , Total Revenue
Fig - 43 Pfizer, Inc., Total Revenue
Fig - 44 Regeneron Pharmaceuticals, Inc. , Total Revenue

Published By: MarketsandMarkets
Product Code: MarketsandMarkets1350


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Biotechnology market as per your needs. Get the best of Biotechnology research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100